Variant report
Variant | esv18823 |
---|---|
Chromosome Location | chr3:24781380-24785615 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538897709 | chr3:24781449-24781450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145394662 | chr3:24781465-24781466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148832929 | chr3:24781483-24781484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112076628 | chr3:24781530-24781531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569049044 | chr3:24781539-24781540 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542706469 | chr3:24781545-24781546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554610441 | chr3:24781621-24781622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7616736 | chr3:24781645-24781646 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs544616986 | chr3:24781654-24781655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374033222 | chr3:24781657-24781658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs59891684 | chr3:24781676-24781677 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs530599323 | chr3:24781677-24781678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533388181 | chr3:24781679-24781680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7616744 | chr3:24781687-24781688 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs141852624 | chr3:24781695-24781696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560279054 | chr3:24781720-24781721 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527789228 | chr3:24781729-24781730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73035584 | chr3:24781780-24781781 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567594164 | chr3:24781796-24781797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531716863 | chr3:24781815-24781816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143439743 | chr3:24781840-24781841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181537541 | chr3:24781862-24781863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114637438 | chr3:24781935-24781936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs114617790 | chr3:24781936-24781937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554021861 | chr3:24781945-24781946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186009525 | chr3:24781982-24781983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116527515 | chr3:24781999-24782000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34622671 | chr3:24782006-24782007 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566436273 | chr3:24782046-24782047 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576843179 | chr3:24782060-24782061 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535458542 | chr3:24782075-24782076 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546074015 | chr3:24782080-24782081 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575985786 | chr3:24782089-24782090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543382138 | chr3:24782092-24782093 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558238665 | chr3:24782112-24782113 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs578207473 | chr3:24782125-24782126 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545254995 | chr3:24782131-24782132 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560316217 | chr3:24782162-24782163 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs77953850 | chr3:24782163-24782164 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542747864 | chr3:24782202-24782203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4342056 | chr3:24782239-24782240 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs569568131 | chr3:24782251-24782252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142032860 | chr3:24782272-24782273 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142773747 | chr3:24782282-24782283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536712485 | chr3:24782284-24782285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371149245 | chr3:24782285-24782286 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs531685558 | chr3:24782296-24782297 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34977362 | chr3:24782297-24782298 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550166435 | chr3:24782330-24782331 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371341166 | chr3:24782335-24782336 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:24776200-24782600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr3:24778000-24781600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr3:24779800-24785200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr3:24780200-24781600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr3:24781400-24782200 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr3:24781600-24782400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
7 | chr3:24781600-24783200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr3:24781600-24783400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr3:24781800-24782600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr3:24781800-24783000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr3:24782000-24782800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr3:24782000-24783200 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr3:24782200-24783000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr3:24782200-24783200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
15 | chr3:24782600-24783800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr3:24783400-24785600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr3:24785200-24785400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |